There is a problem with plasmid access and it is creating a real bottleneck in our process. Do you have any suggestions?
This question is part of the following Ask The Expert session:
Ask the Expert – Transfection Best Practices for AAV Gene Therapy
Answered by:
Answer
The best way to alleviate the bottleneck is to align with a supplier that is capable of manufacturing large-scale GMP-source or GMP plasmids.
This post is sponsored by Corning.